DAWN DENICOLA: Open Payments
NPI 1972917615 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,690 in 49 payments from 16 companies in 2025. Trend: 2023 $1,863 · 2024 $1,596 · 2025 $1,690
Food & beverage: $1,690
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $330 |
| Novartis Pharmaceuticals Corporation | 11 | $212 |
| Medtronic, Inc. | 1 | $187 |
| CVRx, Inc. | 2 | $184 |
| Ancora Heart, Inc. | 1 | $155 |
| Merck Sharp & Dohme LLC | 9 | $141 |
| Lilly USA, LLC | 1 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $67 |
| Novo Nordisk Inc | 2 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $47 |
Products named: LEQVIO, SYMPLICITY G3, Barostim Neo System, REPATHA, AccuCinch, VERQUVO, ZEPBOUND, Kerendia.
Industry payments across LA — which companies pay providers there.
